SHARE EXCHANGE AGREEMENT
Exhibit 10.8
DATED
THIS 31 DECEMBER 2007
Between
BIO-ASPECT SDN. BHD. (COMPANY XX.
000000-X) &
&
XXXXXXXXX XXXXXXXX XXX. BHD. (COMPANY NO.
724705-A)
(hereinafter
collectively referred to as the “VENDORS”)
And
(hereinafter referred to as
the “PURCHASER”)
THIS SHARE EXCHANGE
AGREEMENT (hereinafter
referred to as "this
Agreement") is entered into as of this
31 December 2007,
By and Between
BIO-ASPECT SDN. BHD.
(COMPANY NO. 733606-X) a
company incorporated in
Malaysia and having its business address at 00-0, Xxxxx 0/00X, Xxxxx Xxxxx,
Xxxxx Xxx Xxxxx, Segambut 51200 Kuala Lumpur, Malaysia (hereinafter referred to as
"Bio-Aspect"),
And
EXQUISITE FORESIGHT
SDN. BHD. (COMPANY NO. 724705-A) a company incorporated in Malaysia and
having its business address at Xx. 000, X & X Xxxxxx Xxxxxxx, 00000 Alor
Setar, Kedah, Malaysia (hereinafter referred to as "Exquisite"),
(Bio-Aspect and Exquisite may hereinafter be collectively
referred as “the
Vendors”)
And
RENEWABLE FUEL
CORP., a Nevada corporation
(hereinafter referred to as
the “Purchaser”), with offices at 0000 Xxxx Xxxx Xxxx Xxxx., Xxxxx 000,
Xxx Xxxxx, Xxxxxx 00000;
For the avoidance of doubt, each of the
Vendors and the Purchaser may be referred to herein as a
“Party” and collectively as the “Parties.”
RECITALS
|
A.
|
The Purchaser is a privately held corporation
organized under the laws of the State of
Nevada.
|
|
B.
|
PLANT BIOFUELS
CORPORATION SDN. BHD. (COMPANY NO. 625499-X)
a company incorporated in Malaysia
and having its business address at Xxx 000, 0xx Xxxxx, XXX Xxxxxx, Xx. 0, Xxxxx
Xxxxxxxxxxx Kelana Jaya, 47301 Petaling Jaya, Selangor Darul
Ehsan (hereinafter
referred to as "the
Company”), and
having an authorised share capital of Ringgit Malaysia Twenty Five Million
(RM25,000,000.00) only divided into Twenty Five Million (25,000,000)
ordinary shares of Ringgit Malaysia One (RM1.00) only each of which Twenty
Four Million (24,000,000) ordinary shares have been issued and credited as
fully paid-up (“PBC
Shares”).
|
1
|
C.
|
Bio-Aspect is a privately held corporation organized under the
laws of Malaysia, and is a shareholder of the
Company which holds seventy percent (70%) of the equity or PBC Shares in
the Company.
|
|
D.
|
Exquisite is a privately held corporation organized under the
laws of Malaysia, and is a shareholder of the
Company which holds thirty percent (30%) of the equity or PBC Shares in
the Company.
|
|
E.
|
The Purchaser agrees to acquire the PBC Shares being the whole
100% of the issued
and outstanding securities of the Company from the Vendors
in exchange for the
issuance of certain shares of the Purchaser’s common stock to Vendors (hereinafter referred to
as “the Renewable
Common Stock”)
(hereinafter this exchange be
referred to as the
"Exchange") on the terms described
herein.
|
AGREEMENT
NOW
THEREFORE, based on the
foregoing recitals and for and in consideration of the mutual covenants and agreements hereinafter set
forth and the mutual benefits to the Parties to be derived herefrom, and
intending to be legally bound hereby, the Parties hereby agree as
follows:
ARTICLE
I
REPRESENTATIONS,
COVENANTS, AND WARRANTIES OF BIO-ASPECT
As an inducement to, and to obtain the
reliance of the Purchaser
, except as set forth in
The Company Schedules
(as attached hereafter with this Agreement)
), Bio-Aspect represents and warrants as of the date
hereof and as of the Closing Date, as defined below, as
follows:
Section
1.01 Organization;
Authorization.
The Company is a corporation duly organized, validly
existing, and in good standing under the laws of the country of Malaysia, and has the corporate power and is duly
authorized under all applicable laws, regulations, ordinances, and orders of
public authorities to carry on its business in all material respects
as it is now being conducted. Bio-Aspect has provided to the Purchaser complete and correct copies of the
articles of incorporation, and bylaws of the Company as in effect on the date hereof. The
execution and delivery of this Agreement does not, and the consummation of the
transactions contemplated hereby will not, violate any provision of the Company’s certificate of incorporation or bylaws.
Bio-Aspect has taken all actions required by law,
its certificate of incorporation, or otherwise to authorize the execution and
delivery of this Agreement. Bio-Aspect has full power, authority, and legal
right and has taken all actions required by law, the articles of incorporation of Bio-Aspect, and otherwise to consummate the
transactions herein contemplated.
2
Section
1.02 Organization
of Bio-Aspect; Ownership and Exchange of PBC Shares.
Bio-Aspect is a corporation duly organized, validly
existing, and in good standing under the laws of the country of Malaysia, and has the corporate power and is duly
authorized under all applicable laws, regulations, ordinances, and orders of
public authorities to carry on its business in all material respects
as it is now being conducted. Bio-Aspect owns the number of PBC Shares
set forth opposite his or its name on Exhibit A free and clear of any restrictions on
transfer (other than any restrictions under any applicable current governing laws
, taxes, security
interests, options, warrants, purchase rights, contracts, commitments, equities,
claims, and demands. Bio-Aspect hereby warrants that the Company
is not a party to any
option, warrant, purchase right, or other contract or commitment that could
require Bio-Aspect to sell, transfer, or otherwise dispose of any capital stock
or shares of the Company (other than this
Agreement). Bio-Aspect herby further warrant that the Company
is not a party to any
voting trust, proxy, or other agreement or understanding with respect to the
voting of any capital stock or shares of the Company. The relevant portion of the PBC Shares to be exchanged by Bio-Aspect
have been duly authorized and validly issued and are fully paid and
non-assessable and have not have been issued
in violation of any preemptive right of stockholders or rights of first
refusal. Upon the transfer of the relevant portion of the PBC Shares which belongs to Bio-Aspect herewith
at the Closing,
the Purchaser will acquire good and valid title to
such number of PBC Shares free and clear of all claims,
liens, security interests, pledges, charges, encumbrances, stockholders’
agreements, and voting trusts
Section
1.03 Validity
of Transaction.
Bio-Aspect has full power and authority
(including, if Bio-Aspect is a corporation or other entity, full corporate power
and authority) to execute and deliver this Agreement and to perform his or its
obligations hereunder. All necessary corporate proceedings or other similar
actions by Bio-Aspect have been duly taken to authorize the execution, delivery,
and performance of this Agreement by Bio-Aspect. This Agreement has
been duly executed, and delivered by Bio-Aspect, is the legal, valid, and
binding obligation of Bio-Aspect, and is enforceable as to Bio-Aspect in
accordance with its terms except as may be limited by bankruptcy, insolvency,
moratorium or other similar laws affecting creditors’ rights generally, and
subject to general principles of equity (regardless of whether enforcement is
considered in a proceeding in equity or at law). No consent, authorization,
approval, order, license, certificate, or permit of or from, or declaration or
filing with, any federal, state, local, or other governmental authority or of
any court or other tribunal is required by Bio-Aspect for the execution,
delivery, or performance of this Agreement by Bio-Aspect, except as would not
affect the ability of Bio-Aspect to perform any of its obligations under this
Agreement. No consent of any party to any contract, agreement,
instrument, lease, license, arrangement, or understanding to which Bio-Aspect is
a party, or by which any of its properties or assets is bound, is required for
the execution, delivery, or performance by Bio-Aspect of this Agreement, except
for such consents as have been obtained at or prior to the date of this
Agreement, and except as would not affect the ability of Bio-Aspect to perform
any of its obligations under this Agreement.
3
Neither the execution and the delivery
of this Agreement, nor the consummation of the transactions contemplated hereby,
will (i) violate any constitution, statute, regulation, rule, injunction,
judgment, order, decree, ruling, charge, or other restriction of any government,
governmental agency, or court to which Bio-Aspect is subject or, if Bio-Aspect
is a corporation or other entity, any provision of its charter or bylaws or
comparable organizational documents or, if Bio-Aspect is a partnership, any
provision of its partnership agreement, or (ii) conflict with, result in a
breach of, constitute a default under, result in the acceleration of, create in
any party the right to accelerate, terminate, modify, or cancel, or require any
notice under any agreement, contract, lease, license, instrument, or other
arrangement to which Bio-Aspect is a party or by which he or it is bound or to
which any of his or its assets is subject.
Section
1.04 Investment
Intent.
Bio-Aspect is acquiring the Renewable
Common Stock pursuant hereto for its own account for
investment and not with a view to, or for sale in connection with, any public
distribution thereof in violation of the Securities Act, it being understood
that Bio-Aspect has the right to sell such shares in its sole discretion, and
that by this representation and warranty, Bio-Aspect is not required to hold any
portion of the Renewable Common Stock for any period of time, subject to the
requirements of applicable law. Bio-Aspect understands that such
number of the Renewable Common Stock , as of Closing, have not been
registered for sale under the Securities Act or qualified under applicable state
securities laws, and that the Renewable Common Stock will be delivered to Bio-Aspect pursuant
to one or more exemptions from the registration or qualification requirements of
such securities laws and that the representations and warranties contained in
this Section
1.05 are given with the
intention that the
Purchaser may rely thereon
for purposes of claiming such exemptions.
Section
1.05
Transfer of Renewable Common
Stock.
Bio-Aspect will not sell or otherwise
dispose of any number of
the Renewable Common Stock unless (a) a registration statement
with respect thereto has become effective under the Securities Act and such
securities have been qualified under applicable state securities laws or (b)
such registration and qualification are not required and, if the Purchaser so requests, there is presented to
the Purchaser a legal opinion reasonably satisfactory
to the Purchaser
to such
effect. Bio-Aspect consents that the transfer agent for the
relevant number of the
Renewable Common Stock may be instructed not to transfer any
Renewable Common Stock
unless it receives
satisfactory evidence of compliance with the foregoing provisions, and that
there may be endorsed upon any certificate representing the Renewable
Common Stock (and any certificates issued in
substitution therefor) the following legend calling attention to the foregoing
restrictions on transferability and stating in substance:
"THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE BEEN ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE "SECURITIES ACT"), OR QUALIFICATION UNDER THE BLUE SKY
LAWS OF ANY JURISDICTION. SUCH SECURITIES MAY NOT BE SOLD, ASSIGNED,
TRANSFERRED OR OTHERWISE DISPOSED OF, BENEFICIALLY OR ON THE RECORDS OF THE
CORPORATION, UNLESS THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN
REGISTERED UNDER THE SECURITIES ACT AND QUALIFIED UNDER APPLICABLE BLUE SKY
LAWS, OR AN EXEMPTION FROM SUCH REGISTRATION AND QUALIFICATION IS
AVAILABLE."
4
The Purchaser shall, upon the request of any holder of
a certificate bearing the foregoing legend and the surrender of such
certificate, issue a new certificate without such legend if (i) the security
evidenced by such certificate has been effectively registered under the
Securities Act and qualified under any applicable state securities law and sold
by the holder thereof in accordance with such registration and qualification or
(ii) such holder shall have delivered to the Purchaser a legal opinion reasonably satisfactory
to the Purchaser
to the effect that the
restrictions set forth herein are no longer required or necessary under the
Securities Act or any applicable state law.
ARTICLE
II
REPRESENTATIONS,
COVENANTS, AND WARRANTIES OF EXQUISITE
As an inducement to, and to obtain the
reliance of the
Purchaser, except as set
forth in The Company
Schedules (as attached hereafter with this
Agreement), Exquisite represents and warrants as of the date
hereof and as of the Closing Date, as defined below, as
follows:
Section
2.01 Organization;
Authorization.
The Company is a corporation duly organized, validly
existing, and in good standing under the laws of the country of Malaysia, and has the corporate power and is duly
authorized under all applicable laws, regulations, ordinances, and orders of
public authorities to carryon its business in all material respects as it is now
being conducted. Exquisite
has provided to
the Purchaser complete and correct copies of the
articles of incorporation, and bylaws of the Company as in effect on the date hereof. The
execution and delivery of this Agreement does not, and the consummation of the
transactions contemplated hereby will not, violate any provision of the Company’s certificate of incorporation or bylaws.
Exquisite has taken all actions required by law,
its certificate of incorporation, or otherwise to authorize the execution and
delivery of this Agreement.
Exquisite has full power, authority, and legal
right and has taken all actions required by law, the articles of incorporation of Exquisite, and otherwise to consummate the
transactions herein contemplated.
Section
2.02 Organization
of Exquisite; Ownership and Exchange of PBC Shares.
Exquisite is a corporation duly organized, validly
existing, and in good standing under the laws of the country of Malaysia, and has the corporate power and is duly
authorized under all applicable laws, regulations, ordinances, and orders of
public authorities to carryon its business in all material respects as it is now
being conducted. Exquisite owns the number of PBC Shares set forth
opposite his or its name on Exhibit A-1 free and clear of any restrictions on
transfer (other than any restrictions under any applicable current governing laws
, taxes, security
interests, options, warrants, purchase rights, contracts, commitments, equities,
claims, and demands. Exquisite hereby warrants that the
Company is not a party to
any option, warrant, purchase right, or other contract or commitment that could
require Exquisite to sell, transfer, or otherwise dispose
of any capital stock or
shares of the Company (other than this
Agreement). Exquisite herby further warrant that the Company
is not a party to any
voting trust, proxy, or other agreement or understanding with respect to the
voting of any capital stock or shares of the Company. The relevant portion of the PBC Shares to be exchanged by
Exquisite have been duly authorized and validly
issued and are fully paid and non-assessable and have not have been issued
in violation of any preemptive right of stockholders or rights of first
refusal. Upon the transfer of the relevant portion of the PBC Shares which belongs to Exquisite herewith
at the Closing,
the Purchaser will acquire good and valid title to
such number of PBC Shares free and clear of all claims,
liens, security interests, pledges, charges, encumbrances, stockholders’
agreements, and voting trusts.
5
Section
2.03 Validity of Transaction.
Exquisite has full power and authority
(including, if Exquisite is a corporation or other entity, full corporate power
and authority) to execute and deliver this Agreement and to perform his or its
obligations hereunder. All necessary corporate proceedings or other similar
actions by Exquisite have been duly taken to authorize the execution, delivery,
and performance of this Agreement by Exquisite. This Agreement has
been duly executed, and delivered by Exquisite, is the legal, valid, and binding
obligation of Exquisite, and is enforceable as to Exquisite in accordance with
its terms except as may be limited by bankruptcy, insolvency, moratorium or
other similar laws affecting creditors’ rights generally, and subject to general
principles of equity (regardless of whether enforcement is considered in a
proceeding in equity or at law). No consent, authorization, approval, order,
license, certificate, or permit of or from, or declaration or filing with, any
federal, state, local, or other governmental authority or of any court or other
tribunal is required by Exquisite for the execution, delivery, or performance of
this Agreement by Exquisite, except as would not affect the ability of Exquisite
to perform any of its obligations under this Agreement. No consent of
any party to any contract, agreement, instrument, lease, license, arrangement,
or understanding to which Exquisite is a party, or by which any of its
properties or assets is bound, is required for the execution, delivery, or
performance by Exquisite of this Agreement, except for such consents as have
been obtained at or prior to the date of this Agreement, and except as would not
affect the ability of Exquisite to perform any of its obligations under this
Agreement.
Neither the execution and the delivery
of this Agreement, nor the consummation of the transactions contemplated hereby,
will (i) violate any constitution, statute, regulation, rule, injunction,
judgment, order, decree, ruling, charge, or other restriction of any government,
governmental agency, or court to which Exquisite is subject or, if Exquisite is a corporation or other entity, any
provision of its charter or bylaws or comparable organizational documents or, if
Exquisite is a partnership, any provision of its
partnership agreement, or (ii) conflict with, result in a breach of, constitute
a default under, result in the acceleration of, create in any party the right to
accelerate, terminate, modify, or cancel, or require any notice under any
agreement, contract, lease, license, instrument, or other arrangement to which
Exquisite is a party or by which he or it is bound
or to which any of his or its assets is subject.
Section
2.04 Investment
Intent.
Exquisite is acquiring the Renewable Common Stock pursuant hereto for its own account for
investment and not with a view to, or for sale in connection with, any public
distribution thereof in violation of the Securities Act, it being understood
that Exquisite has the right to sell such shares in its
sole discretion, and that by this representation and warranty, Exquisite is not required to hold any portion of the Renewable Common Stock for any period of time, subject to the
requirements of applicable law. Exquisite understands that such number of the Renewable Common Stock , as of Closing, have not been
registered for sale under the Securities Act or qualified under applicable state
securities laws, and that the Renewable Common Stock will be delivered to Exquisite pursuant to one or more exemptions from
the registration or qualification requirements of such securities laws and that
the representations and warranties contained in this Section
1.05 are given with the
intention that the
Purchaser may rely thereon
for purposes of claiming such exemptions.
6
Section
2.05 Transfer
of Renewable Common
Stock.
Exquisite will not sell or otherwise dispose of
any number of the
Renewable Common Stock unless (a) a registration statement with
respect thereto has become effective under the Securities Act and such
securities have been qualified under applicable state securities laws or (b)
such registration and qualification are not required and, if the Purchaser so requests, there is presented to
the Purchaser a legal opinion reasonably satisfactory
to the Purchaser
to such effect.
Exquisite consents that the transfer agent for the
relevant number of the
Renewable Common Stock may be instructed not to transfer any
Renewable Common Stock
unless it receives
satisfactory evidence of compliance with the foregoing provisions, and that
there may be endorsed upon any certificate representing the Renewable
Common Stock (and any certificates issued in
substitution therefor) the following legend calling attention to the foregoing
restrictions on transferability and stating in substance:
"THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE BEEN ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE "SECURITIES ACT"), OR QUALIFICATION UNDER THE BLUE SKY
LAWS OF ANY JURISDICTION. SUCH SECURITIES MAY NOT BE SOLD, ASSIGNED,
TRANSFERRED OR OTHERWISE DISPOSED OF, BENEFICIALLY OR ON THE RECORDS OF THE
CORPORATION, UNLESS THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN
REGISTERED UNDER THE SECURITIES ACT AND QUALIFIED UNDER APPLICABLE BLUE SKY
LAWS, OR AN EXEMPTION FROM SUCH REGISTRATION AND QUALIFICATION IS
AVAILABLE."
The Purchaser shall, upon the request of any holder of
a certificate bearing the foregoing legend and the surrender of such
certificate, issue a new certificate without such legend if (i) the security
evidenced by such certificate has been effectively registered under the
Securities Act and qualified under any applicable state securities law and sold
by the holder thereof in accordance with such registration and qualification or
(ii) such holder shall have delivered to the Purchaser a legal opinion reasonably satisfactory
to the Purchaser
to the effect that the
restrictions set forth herein are no longer required or necessary under the
Securities Act or any applicable state law.
7
ARTICLE
III
REPRESENTATIONS,
COVENANTS, AND WARRANTIES OF THE PURCHASER
As an inducement to, and to obtain the
reliance of Bio-Aspect and
Exquisite, except as set forth in the Renewable Schedules (as attached hereinafter), the Purchaser represents and warrants, as of the
date hereof and as of the Closing Date, as
follows:
Section
3.01 Organization;
Authorization.
The Purchaser is a corporation incorporated in
the State of Nevada, is in good standing with all
applicable agencies. Included in the Renewable Schedules are complete and correct
copies of the certificate of incorporation, and bylaws of the Purchaser as in effect on the date hereof. The execution
and delivery of this Agreement does not, and the consummation of the transactions contemplated hereby
will not, violate any provision of the Purchaser’s s articles of incorporation or bylaws. The Purchaser has taken all actions required by law,
its certificate of incorporation, or otherwise to authorize the execution and
delivery of this Agreement.
Section
3.02 Legal
Proceedings.
There are no legal actions against
the Purchaser or its directors, officers, or shareholders, and
the Purchaser knows of no threatened legal actions
against the
Purchaser, its directors, officers, or shareholders,
nor is the Purchaser
engaged in any legal
actions against other parties.
The business and financial condition
of the Purchaser
are as set forth in
the financial statements of
the Purchaser provided to the Vendors as of the date
hereof.
Section
3.04 Capitalization.
As of the date of this Agreement,
the
Purchaser’s authorized capitalization consists of 100,000,000 shares of common stock, par value
$0.0001 per share, of which 6,500,000 shares are issued and
outstanding.. All issued and outstanding shares are
legally issued, fully paid, and non-assessable and not issued in
violation of the preemptive or other rights of any
person.
ARTICLE
IV
THE
EXCHANGE
Section 4.01 The
Exchange.
(a) The Exchange
by the
Vendors and the Purchaser.
On the terms and subject to the conditions set forth in this Agreement, the Vendors shall assign, transfer and deliver, free and clear of
all liens, pledges, encumbrances, charges, restrictions or known claims of any kind, nature, or
description, the PBC Shares
in the Company set forth on
Schedule A attached hereto, constituting the voting shares of common stock, of
the Company held by such Vendors; the objective of the Exchange being the acquisition
by the
Purchaser of the whole 100% of the issued and outstanding
common stock of the
Company.
8
(b) In exchange for the
transfer of the PBC Shares
by the Vendors, the Purchaser shall issue to the Vendors the Renewable Common Stock in
an aggregate of
73,000,000 shares of restricted common stock for the Vendors
(c) It is the intention of
the parties that immediately following the Closing, on the date of the Closing (hereinafter referred to as the “Closing
Date”):
(i) There will be an aggregate of
80,960,000 shares in the Purchaser issued and outstanding
(hereinafer referred to as “Renewable Total Common Stock”).
(ii) Of those 80,960,000 shares, the Vendors will hold an aggregate of 73,000,000 shares from the said Renewable Total
Common Stock, the remaining
existing Purchaser
shareholders will hold
an aggregate of 6,500,000 shares of Renewable Total Common Stock and there will be an additional new
issuance of shares in the amount of 1,460,000 to be issued to a third party
pursuant to a separate private arrangement.
(d) At the Closing, on
surrender by the Vendors
of their certificate
or certificates representing the
PBC Shares to the Purchaser or its registrar or transfer agent, each
Vendor shall receive a certificate
or certificates evidencing his or her
proportionate interest in the Renewable Common Stock, respectively.
(e) It is not the intention of
the Parties to create a new class of Renewable Total Common Stock in connection with the restrictive
nature of a portion of the stock issued.
(f) The parties hereby
also acknowledge and aware that in addition to the Renewable Total Common Stock
above, at the Closing the Purchaser will issue a share option to a third party
which share option enables the third party to purchase 3,650,000 shares in the
Purchaser at USD$0.10 per share exercisable within 10 years from the date
hereof.
Section
4.02 Anti-Dilution.
The number of shares of Renewable Total Common Stock issuable upon the Exchange pursuant to Section
3.01 shall be appropriately
adjusted to take into account any stock split, stock dividend, reverse stock split,
recapitalization, or similar change in the Renewable Total Common Stock which may occur, between the date of the
execution of this Agreement and the Closing
Date.
9
Section
4.03 Closing
Events.
At the Closing, the Purchaser and the Vendors
shall execute, acknowledge, and deliver (or shall
ensure to be executed, acknowledged, and delivered), any and all certificates, opinions, financial
statements, schedules, agreements, resolutions, rulings or other
instruments required by this Agreement to be so
delivered at or prior to the Closing, as applicable, together with
such other items as may be reasonably
requested by the parties hereto and their respective legal counsel in
order to effectuate or evidence the
transactions contemplated hereby.
Section
4.04 Closing.
The
Closing Date of this Agreement shall be thirty (30) days from the Date of this
Agreement.
Section 4.05
Termination.
This Agreement may be terminated by the
Board of Directors of the
Purchaser or the Vendors in the event that the Purchaser or the Vendors
do not meet the conditions
precedent set forth in Articles VI and
VII, or if an event of
default shall have occurred, and shall not have been cured within fifteen (15)
days of the occurrence of such default. If this Agreement is terminated
pursuant this section, this Agreement shall be of no further force or effect, and no
obligation, right or liability shall arise hereunder. For purposes of this
Agreement, “Event of
Default” shall mean (a) the
breach by any Party to this Agreement of any of the material terms of this
Agreement; or (b) the failure or refusal by any Party to this Agreement to
complete the transactions contemplated by this Agreement. In the
event of a default by the defaulting party, the non-defaulting
party shall be entitled to receive, as liquidated damages and not as
a penalty, the sum of US$700,000.00 from the defaulting party. Additionally, in
the event this Agreement is terminated pursuant to this Section
4.05, the Parties hereby
agree to return, to their respective owners or producers, any and all documents
in their possession relating to the transaction contemplated by this Agreement
within ten (10) days of such termination.
ARTICLE
V
SPECIAL
COVENANTS
Section
5.01 Access
to Properties and Records.
The Purchaser and the
Vendors will
each afford to the officers and authorized representatives
of the other full access to the properties, books and records of the Purchaser or the Company as the case may be, in order that each
may have a full opportunity to make such reasonable investigation as it shall
desire to make of the affairs of the other, and each will furnish the
other with such additional financial and
operating data and other information as to the business and properties
of the
Purchaser or
the Company as the case may be, as the other shall
from time to time reasonably request.
10
Section
5.02 Delivery of Books and Records.
At the Closing, the Vendors shall deliver to the Purchaser the originals of the corporate minute books,
books of account, contracts, records, and all other books or documents of the Company now in the possession of either of the Vendors or their representatives.
Section
5.03 Third Party Consents and Certificates.
The Purchaser and the Vendors agree to cooperate with each other in order to obtain any
required third party consents to this Agreement and the transactions herein contemplated.
Section
5.04 Additional Actions
Prior to Closing.
(a) From and after the date
of this Agreement until the Closing and except as set forth in the Renewable Schedules or the Company’s Schedules or as permitted or
contemplated by this Agreement, the Purchaser (subject to paragraph (iv) below) and
the
Vendors (with respect to the Company , respectively, will
each:
(i) carry on its business in
substantially the same manner as it has heretofore;
(iii) maintain in full force
and effect insurance comparable in amount and in scope of coverage to that now maintained by
it;
(iv) perform in all material
respects all of its obligations under material contracts, leases, and instruments relating to or
affecting its assets, properties, and business;
(v) use commercially
reasonable care, diligence and skill to maintain and preserve
its business organization intact, to retain
its key employees, and to maintain its relationship with its material suppliers and customers;
and
(vi) fully comply with and
perform in all material respects all obligations and duties imposed on it by all federal and state
laws and all rules, regulations, and orders imposed by federal or state governmental
authorities.
(b) From and after the date
of this Agreement until the Closing, neither the Purchaser nor the Vendors (on behalf of the Company
will:
(i) make any changes in their
respective certificate of incorporation or bylaws except as contemplated by this
Agreement;
11
(ii) enter into or amend any
contract, agreement, or other instrument of any of the types described in such party's
schedules, except that a party may enter into or amend any contract, agreement, or other instrument
in the ordinary course of business involving the sale of goods or services;
or
(iii) sell any assets or
discontinue any operations, sell any shares of capital stock or conduct any similar transactions other
than in the ordinary course of business.
Section
5.05 Indemnification.
(a) The Vendors agree to indemnify the Purchaser and each of the officers, agents and directors of
the Purchaser as of the date of execution of this
Agreement against any Loss to which it or they may become
subject arising out of or based on any claim which is finally determined by a court of competent
jurisdiction that (i) the Vendors did not have good title to the PBC Shares or (ii) that the PBC Shares were subject to a
lien or encumbrance. The indemnification
provided for in this paragraph shall survive the Closing and consummation of the transactions
contemplated hereby and termination of this Agreement for one year following the Final
Closing.
(b) The Purchaser hereby agrees to indemnify the
Vendors as of the date of execution of this
Agreement against any Loss to which it or they may become
subject arising out of or based on any inaccuracy appearing in or misrepresentation made under
Article III of this Agreement. The indemnification
provided for in this paragraph shall survive the Closing
and consummation of the transactions contemplated hereby and termination of this Agreement for
one year following the Final Closing.
(c ) The Vendors hereby jointly
and severally covenant with the Purchaser that they will indemnify and at all
time keep the Purchaser indemnified against any tax liability or taxation
assessable or recoverable on or from the Company to the extent of their tax
liability in relation to profits of the Company prior to the Closing Date,
unless the same has been disclosed to the Purchaser in
writing.
(d) Notwithstanding
the completion of the Exchange all warranties, undertakings, covenants,
representations and obligations of the Vendors herein contained shall continue
thereafter to subsist for so long as may be necessary to give effect to each and
every one of them in accordance with the terms thereof. The Vendors hereby
jointly and severally undertake to, and covenant and agree with the Purchaser
that they shall at all times hereafter keep the Purchaser fully and effectively
indemnified against any depletion or diminution of the assets of the Company and
any loss, damage, cost and expense which the Purchaser may directly or
indirectly suffer as a result of or in connection with any misrepresentation
contained herein or any breach of any of the warranties, covenants and
obligations set out herein. In particular, the Parties hereby agree that the
Vendors shall indemnify the Purchaser for any claims, expenses, losses, damages,
suits or any actions whatsoever caused or incurred by the Vendors to the
Company, whether jointly or severally prior to the Closing.
12
Section
5.06 The
Acquisition of Renewable Common Stock.
The Purchaser and the Vendors understand and agree that the consummation of this
Agreement including the issuance of the Renewable Common
Stock to the
Vendors in the Exchange for the PBC Shares as contemplated hereby
constitutes the offer and sale of securities under the Securities Act of 1933, as
amended (hereinafter
referred to as the
“Securities
Act”) and applicable state statutes. The Purchaser and the Vendors agree that such transactions shall be
consummated in reliance on exemptions from the registration and prospectus
delivery requirements of such statutes, which depend, among other items, on the circumstances under which
such securities are acquired.
(a) In order to provide
documentation for reliance upon the exemptions from the registration and prospectus delivery
requirements for such transactions, each Vendor shall execute and deliver to the Purchaser a Suitability Letter and an Investment
Representation Letter in substantially the same form as that attached hereto as Exhibit
SL and Exhibit
IRL ,
respectively.
(b) In connection with the
transaction contemplated by this Agreement, the Purchaser and the Vendors shall each file, with the assistance of
the other and their respective legal counsel, such notices, applications, reports, or other
instruments as may be deemed by them to be necessary or appropriate in an effort to document reliance on
such exemptions, and the appropriate regulatory authority in the states where the the Vendors reside unless an exemption requiring no
filing is available in such jurisdictions, all to the extent
and in the manner as may be deemed by such parties to be appropriate.
(c) In order to more fully
document reliance on the exemptions as provided herein, the Vendors and the Purchaser shall execute and deliver to the other,
at or prior to the Closing, such further letters of representation, acknowledgment,
suitability, or the like as the Vendors or the Purchaser and their respective counsel may reasonably request in
connection with reliance on exemptions from registration under such securities
laws.
(d) The Vendors acknowledge that the basis for relying
on exemptions from registration or qualifications are factual, depending on the conduct of the
various parties, and that no legal opinion or other assurance will be required or given to the effect
that the transactions contemplated hereby are in fact exempt from registration or
qualification.
(e) The
Vendors shall grant and shall cause the Company to grant the Purchaser their
full cooperation in allowing the Purchaser to conduct the due diligence. The
Purchaser shall complete the due diligence and notify the Vendors in writing
whether or not it is satisfied with the findings of the due diligence before the
expiry of the Stipulated Period (as hereinafter defined).
13
(f) In
return for the cooperation outlined in Section 5.10 (e) above, the
Purchaser shall grant the Vendors their full cooperation in allowing the Vendors
to conduct the due diligence. The Vendors shall complete the due diligence and
notify the Purchaser in writing whether or not it is satisfied with the findings
of the due diligence before the expiry of the Stipulated Period (as hereinafter
defined).
ARTICLE
VI
CONDITIONS
PRECEDENT TO OBLIGATIONS OF THE PURCHASER
The obligations of the Purchaser under this Agreement are subject to the
satisfaction, at or before Closing, of the following
conditions:
Section
6.01 Accuracy of Representations and Performance of
Covenants.
The representations and warranties made by the Vendors in this Agreement were true when made
and shall be true at Closing with the same force and effect as if such
representations and warranties were made at and as of Closing (except
for changes therein permitted by this
Agreement). The Vendors
shall have performed or
complied with all covenants and conditions required by this
Agreement to be performed or complied with by the Vendors prior to or at the Closing. The Purchaser shall be furnished with a certificate,
signed by each of the
Vendors and dated the
Closing Date, to the foregoing effect.
Section
6.02 Information Provided.
The Purchaser shall have been furnished with that
information on the business and affairs of
the Company which it deems, in its sole and absolute
discretion, to be necessary for it to make its decision to proceed with the
Closing.
Section
6.03 No Material Adverse Change.
As of the Closing there shall not have
occurred any material adverse change, financially or
otherwise, which materially impairs the ability of the Company to conduct its business or the earning power
thereof.
Section
6.04 Financial Statements.
The Company shall have completed its audited consolidated financial statements and shall have provided such to the
Purchaser .
Section
6.05 Due
Diligence.
Each of Bio-Aspect and Exquisite shall
have provided to the Purchaser, to the satisfaction of the Purchaser, the
information of the Company as set forth in The Company Schedules 6.06 (a)
through (m). The Purchaser shall have the right, in addition
to any rights to terminate this Agreement set forth in Section 4.05 above, to
terminate this transaction in the event that (a) either Bio-Aspect or Exquisite
shall not provide all the required information in relation to the Company in its
possession to the satisfaction of the Purchaser; or (b) the Purchaser shall
determine in its sole discretion, based on reviews of the materials provided by
Bio-Aspect or Exquisite in The
Company Schedules 6.06, that it is not in the best interest of the
Purchaser to continue with the transactions contemplated by this
Agreement.
14
ARTICLE
VII
CONDITIONS
PRECEDENT TO OBLIGATIONS OF THE VENDORS
The obligations of the Vendors under this Agreement are subject
to the satisfaction, at or before the
Closing Date, of the following conditions:
Section
7.01 Accuracy of Representations and Performance of
Covenants.
The representations and warranties made by the Purchaser in this Agreement were true when made
and shall be true as of the Closing Date (except for changes therein
permitted by this Agreement) with the same force and effect as if such representations and warranties were
made at and as of the Closing Date. Additionally, the Purchaser shall have performed and complied with all
covenants and conditions required by this Agreement to be performed or complied with by the Purchaser.
Section
7.02 Issuance of Shares.
Shares of the Renewable Common Stock to be issued by the Purchaser to the Vendors at Closing shall have been
issued.
Section
7.03 Due
Diligence.
The Purchaser shall have provided to the Vendors to the satisfaction of the Vendors, the information of the Purchaser as set forth in the Renewable
Schedule. The Vendors shall have the right, in addition to any
rights to terminate this Agreement set forth in Section
4.05 above, to terminate
this transaction in the event that (a) the Purchaser shall not provide all the
required information in its possession to the satisfaction of the Vendors; or
(b) the Vendors shall determine in its sole discretion, based on its review of
the materials provided by the Purchaser, that it is not in the best interest of
the Vendors to continue with the transactions contemplated by this
Agreement.
ARTICLE
VIII
MISCELLANEOUS
Section
8.01 Brokers.
The Purchaser and the
Vendors agree that, except as set out on Schedule 8.01
of the Renewable Schedules and the Company Schedules, there were no finders or brokers involved in bringing
the parties together or who were instrumental in the negotiation, execution or consummation of this
Agreement. The Purchaser
and the Vendors each agree to indemnify the
other against any claim by any third person
other than those described above for any commission, brokerage, or finder's fee arising from the
transactions contemplated hereby based on any alleged agreement or understanding between the indemnifying
party and such third person, whether express or implied from the actions of the indemnifying
party.
15
Section
8.02 Governing Law.
(a) The parties hereby agree that for
purposes of compliance, each party shall be governed by all its relevant current
applicable governing laws
(b) This Agreement shall be governed by,
enforced, and construed under and in accordance with the laws of the United
States of America and with respect to the matters of state laws, with the laws
of the State of Nevada.
(c) Any dispute, controversy or claim
arising out of or relating to this Agreement, or the breach, termination or
invalidity thereof, shall be settled by arbitration in accordance with the
UNITRAL Arbitration Rules as present in force. The appointing authority shall be
the Singapore International Arbitration Centre. The number of arbitrators shall
be three (3). The place of arbitration shall be Singapore and the language to be
used in the arbitral proceedings shall be English.
Section
8.03 Notices.
Any notice or other communications
required or permitted hereunder shall be in writing and shall be
sufficiently given if personally delivered to it or sent by telecopy,
overnight courier or registered mail or certified
mail, postage prepaid, addressed as follows:
If to Bio-Aspect, to:
|
00-0, Xxxxx 0/00X, Xxxxx Xxxxx,
Xxxxx Xxx Xxxxx, Segambut 51200 Kuala Lumpur, Malaysia
|
If to Exquisite,
to:
|
Xx. 000, X & X Xxxxxx Xxxxxxx,
00000 Alor Setar, Kedah,
Malaysia
|
If to the Purchaser, to:
|
Xxxxxxx
XxxXxxxx
0000 Xxxx Xxxx Xxxx Xxxxxxxxx
Xxxxx 000
Xxx Xxxxx, Xxxxxx
00000
Tel:
x0-000-000-0000
Fax:
x0-000-000-0000
|
16
With copies
to:
|
C. Xxxxxxxxx Xxxxx,
Esq.
Xxxxxx Xxxxx & Xxxxxxx,
P.C.
000 Xxxx Xxxxxxxx, Xxxxx 000
Xxxx Xxxx Xxxx, Xxxx
00000
Tel: 000-000-0000
Fax:
000-000-0000
|
or such other addresses as shall be
furnished in writing by any party in the manner for giving notices hereunder, and any such notice or
communication shall be deemed to have been given (i) upon receipt,
if personally delivered, (ii) on the day
after dispatch, if sent by overnight courier, (iii) upon dispatch,
if transmitted by telecopy and receipt is
confirmed by telephone and (iv) three (3) days after mailing, if
sent by registered or certified
mail.
Section
8.04 Attorney's Fees.
In the event that either party
institutes any action or suit to enforce this Agreement or to secure
relief from any default hereunder or breach hereof, the prevailing
party shall be reimbursed by the losing party
for all costs, including reasonable attorney's fees, incurred in connection therewith and in enforcing or
collecting any judgment rendered therein.
Section
8.05 Confidentiality.
Each party hereto agrees with the other
that, unless and until the transactions contemplated by this
Agreement have been consummated, it and its representatives will hold
in strict confidence all data and
information obtained with respect to another party or any subsidiary
thereof from any representative, officer,
director or employee, or from any books or records or from personal inspection, of such other party, and
shall not use such data or information or disclose the same to
others, except (i) to the extent such data or
information is published, is a matter of public knowledge, or is
required by law to be published; or (ii) to the
extent that such data or information must be used or disclosed in
order to consummate the transactions
contemplated by this Agreement. In the event of the termination of
this Agreement, each party shall return to
the other party all documents and other materials obtained by it or
on its behalf and shall destroy all copies,
digests, work papers, abstracts or other materials relating thereto,
and each party will continue to comply with
the confidentiality provisions set forth herein.
Section
8.06 Schedules; Knowledge.
Each party is presumed to have full
knowledge of all information set forth in the other
party's schedules delivered pursuant to this Agreement.
Section
8.07 Third Party Beneficiaries.
This contract is strictly between
the
Purchaser and the Vendors , and, except as specifically provided,
no director, officer, stockholder (other than the Vendors), employee, agent, independent
contractor or any other person or entity shall be deemed to be a third
party beneficiary of this Agreement.
17
Section
8.08 Expenses.
Subject to Section
7.04 above, whether or not
the Exchange is consummated, each of the Purchaser and the Vendors will bear its own respective expenses, including
legal, accounting and professional fees,
incurred in connection with the Exchange or any of the other
transactions contemplated hereby.
Section
8.09 Entire Agreement.
This Agreement represents the entire
agreement between the parties relating to the subject matter
thereof and supersedes all prior agreements, understandings and negotiations, written or oral, with
respect to such subject matter.
Section
8.10 Survival; Termination.
The representations, warranties, and
covenants of the respective parties shall survive the
Closing Date and the consummation of the transactions herein contemplated for a period of two
years.
Section
8.11 Counterparts.
This Agreement may be executed in
multiple counterparts, each of which shall be deemed an original and
all of which taken together shall be but a single
instrument.
Section
8.12 Amendment or Waiver.
Every right and remedy provided herein
shall be cumulative with every other right and
remedy, whether conferred herein, at law, or in equity, and may be enforced concurrently herewith, and no
waiver by any party of the performance of any obligation by the other shall be construed as a waiver of
the same or any other default then, theretofore, or thereafter occurring or existing. At any time prior
to the Closing Date, this Agreement may by amended by a writing signed by all parties hereto, with
respect to any of the terms contained herein, and any term or condition
of this Agreement may be waived or the time
for performance may be extended by a writing signed by the party or parties for whose benefit the
provision is intended.
[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK.
SIGNATURE PAGES
FOLLOW.]
18
IN WITNESS
WHEREOF, the corporate
parties hereto have caused this Agreement to be executed by their respective officers, hereunto duly
authorized, as of the date first-above written.
By: /s/
Xxxxxxx
XxxXxxxx
|
|
Name: Xxxxxxx
XxxXxxxx
|
|
Title:
President
|
|
BIO-ASPECT
S/B
|
|
By: /s/ /s/
|
|
Name: Tan Xxx
Xxxx Xxxxx Xxxxxx Bin Hj.
Jaafar
|
|
Title: Director Director
|
|
EXQUISITE FORESIGT
S/B
|
|
By: /s/
|
|
Name: Tan Xxx
Xxxx
|
|
Title: Director
|
|
19
Exhibit SL
SUITABILITY
LETTER
(TO BE COMPLETED BY EACH OF THE VENDORSS)
TO: Renewable Fuel Corp.
I make the following representations
with the intent that they may be relied on by Renewable Fuel Corp. (the "Company"), in determining my suitability as a
purchaser of securities of the Company (the "Shares").
2. I have had the opportunity
to ask questions of, and receive answers and information, from the officers of the Company and I deemed
such information sufficient to make an investment decision on the Company.
3. I have such knowledge and
experience in business and financial matters that I am capable of evaluating the Company, its business
activities, and the risks and merits of this prospective investment, and
I am
not utilizing a purchaser
representative (as defined in regulation D) in connection with the evaluation
of such risks and merits, except as set
forth in paragraph 3.
4. I shall provide a separate
written statement from each purchaser representative on the
Purchaser Representative Acknowledgment form
available from the Company in which is disclosed (i) the
relationship of the purchaser representative with the
Company, if any, which has existed at any time during the previous two years, and compensation received or
to be received as a result of such relationship, and (ii) the education, experience, and knowledge in
financial and business matters which enables the purchaser representative to evaluate the relative
merits 7and risks of an investment in the
Company.
5. The undersigned and the
purchaser representatives listed above, if any, together have such knowledge and experience in financial
and business matters that they are capable of evaluating the Company and the proposed activities thereof and
the merits and risks of this prospective investment.
6. I have adequate means of
providing for my current needs and possible personal contingencies
and have no need in the foreseeable future
for liquidity of an investment in the Company.
7. Instructions: Complete
either (a) or (b) below, as applicable:
(a) FOR
ACCREDITED INVESTORS. I
confirm that I am an "accredited investor" as defined under rule 501 of regulation D
promulgated under the Securities Act of 1933, as amended (the
"Securities Act"), as checked
below:
20
(i) Any bank as defined in
section 3(a)(2) of the Securities Act or any savings and loan association or other institution as
defined in section 3(a)(5)(A) of the Securities Act whether acting in
its individual or fiduciary capacity; any
broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; any insurance
company as defined in section 2(13) of the Securities Act; any investment company registered under the
Investment Company Act of 1940 or a business development company as defined in section 2(a)(48)
of that Act; any small business investment company licensed by the U. S. Small Business Administration
under section 301(c) or (d) of the Small Business Investment Act of1958; any
plan established and maintained by a state, its political subdivisions, or any
agency or instrumentality of a state or its
political subdivisions, for the benefit of its employees, if such plan has
total assets in excess of $5,000,000; any
employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the
investment decision is made by a plan fiduciary, as defined in section3(21) of
such Act, which is either a bank, savings and loan association, insurance
company, or registered investment adviser, or if the employee
benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment
decisions made solely by persons that are accredited
investors;
o Yes o No
(ii) Any private business
development company as defined in section 302(a)(22) of the Investment Advisers Act of
1940;
o Yes o No
(iii) Any organization
described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar
business trust, or partnership, not formed for the specific purpose
of acquiring the securities offered, with
total assets in excess of $5,000,000;
o Yes o No
(iv) Any director, executive
officer, or general partner of the issuer of the securities being offered or sold, or any director,
executive officer, or general partner of a general partner of that
issuer;
o Yes o No
(v) Any natural person whose
individual net worth or joint net worth with that person's spouse, at the time of his or her
purchase exceeds $1,000,000;
o Yes o No
For purposes of category (v), the term
"net worth" means the excess of total assets over total liabilities. In computing net worth for
the purposes of category (v) above, the undersigned's principal residence must be valued either at (A)
cost, including the cost of improvements, net of current encumbrances upon the property or (B)
the appraised value of the property as determined upon a written appraisal used by an institutional
lender making a loan to the individual secured by the property,
including the cost of subsequent improvements, net
of current encumbrances upon the property.
21
(vi) Any natural person who
had an individual income in excess of $200,000 in each of the two most recent years or joint
income with that person's spouse in excess of $300,000 in each of
those years and has a reasonable expectation
of reaching the same income level in the current year;
o Yes o No
In determining income, the undersigned
should add to his or her adjusted gross income any amounts attributable to tax exempt income
received, losses claimed as a limited partner in any limited
partnership, deductions claimed for depletion,
contributions to an XXX or Xxxxx retirement plan, alimony payments,
and any amount by which income from
long-term capital gains has been reduced in arriving at adjusted
gross income.
(vii) Any trust, with total
assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities
offered, whose purchase is directed by a sophisticated person as
described in section 230.506(b)(2)(ii);
and
o Yes o No
(viii) Any entity in which
all of the equity owners are accredited investors.
o Yes o No
(b) FOR
NONACCREDITED INVESTORS. I
am not an accredited
investor.
The following
information is being provided here in lieu of furnishing a personal financial
statement.
(i) My net worth excluding
principal residence, furnishings, and automobiles is at least ______________ times the total investment I intend
to make in the Company;
(ii) My annual disposable
income, after excluding all of my personal and family living expenses and other cash requirements for
current obligations, is such that the loss of my entire investment
in the Company would not materially alter
my standard of living;
o Yes o No
(iii) Considering the
foregoing and all other relevant factors in my financial and
personal circumstances, I am able to bear the
economic risk of an investment in the Company.
o Yes o No
22
7. I have previously been
advised that I would have an opportunity to review all the pertinent
facts concerning the Company, and to obtain
any additional information which I might request, to the extent possible or obtainable, without
unreasonable effort and expense, in order to verify the accuracy of
the information provided me.
8. I have personally
communicated or been offered the opportunity to communicate with
executive officers of the Company to discuss the
business and financial affairs of the Company, its products and activities, and its plans for the
future. I acknowledge that if I would like to further avail myself of
the opportunity to ask additional questions
of the Company, the Company will make arrangements for such an opportunity on
request.
9. I have been advised that
no accountant or attorney engaged by the Company is acting as my representative, accountant, or
attorney.
10. I will hold title to my
interest as follows:
o
|
Community
Property
|
o
|
Separate
Property
|
o
|
Joint Tenants, with Right
of Survivorship
|
o
|
Tenants in
Common
|
o
|
Other (Single Person, Trust, Etc.,
Please Indicate.)
|
||
_________________________________
|
11. I am a bona fide resident
of the state of __________. The address below is my true and correct principal residence.
DATED this 31 day of December , 2007
/s/ Dato’
Xxxxx Xxxxxx Bin Hj. Jaafar
Name: Dato’ Xxxxx
Xxxxxx Bin Hj. Jaafar
NRIC No.
6701420-01-5763
Address: Xx. 0, Xxxxx Xxxxxx Xxxxx,
Xxxxxxxx,
00000 Xxxxxx Xxxxx, Xxxxxxxx Darul Ehsan.
For and on behalf of
Bio-Aspect Sdn. Bhd. (Company No.
733606-X)
23
Exhibit SL
SUITABILITY
LETTER
(TO BE COMPLETED BY EACH OF THE VENDORSS)
TO: Renewable Fuel Corp.
I make the following representations
with the intent that they may be relied on by Renewable Fuel Corp. (the "Company"), in determining my suitability as a
purchaser of securities of the Company (the "Shares").
2. I have had the opportunity
to ask questions of, and receive answers and information, from the officers of the Company and I deemed
such information sufficient to make an investment decision on the Company.
3. I have such knowledge and
experience in business and financial matters that I am capable of evaluating the Company, its business
activities, and the risks and merits of this prospective investment, and
I am
not utilizing a purchaser
representative (as defined in regulation D) in connection with the evaluation
of such risks and merits, except as set
forth in paragraph 3.
4. I shall provide a separate
written statement from each purchaser representative on the
Purchaser Representative Acknowledgment form
available from the Company in which is disclosed (i) the
relationship of the purchaser representative with the
Company, if any, which has existed at any time during the previous two years, and compensation received or
to be received as a result of such relationship, and (ii) the education, experience, and knowledge in
financial and business matters which enables the purchaser representative to evaluate the relative
merits 7and risks of an investment in the
Company.
5. The undersigned and the
purchaser representatives listed above, if any, together have such knowledge and experience in financial
and business matters that they are capable of evaluating the Company and the proposed activities thereof and
the merits and risks of this prospective investment.
6. I have adequate means of
providing for my current needs and possible personal contingencies
and have no need in the foreseeable future
for liquidity of an investment in the Company.
7. Instructions: Complete
either (a) or (b) below, as applicable:
(a) FOR
ACCREDITED INVESTORS. I
confirm that I am an "accredited investor" as defined under rule 501 of regulation D
promulgated under the Securities Act of 1933, as amended (the
"Securities Act"), as checked
below:
24
(i) Any bank as defined in
section 3(a)(2) of the Securities Act or any savings and loan association or other institution as
defined in section 3(a)(5)(A) of the Securities Act whether acting in
its individual or fiduciary capacity; any
broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; any insurance
company as defined in section 2(13) of the Securities Act; any investment company registered under the
Investment Company Act of 1940 or a business development company as defined in section 2(a)(48)
of that Act; any small business investment company licensed by the U. S. Small Business Administration
under section 301(c) or (d) of the Small Business Investment Act of1958; any
plan established and maintained by a state, its political subdivisions, or any
agency or instrumentality of a state or its
political subdivisions, for the benefit of its employees, if such plan has
total assets in excess of $5,000,000; any
employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the
investment decision is made by a plan fiduciary, as defined in section3(21) of
such Act, which is either a bank, savings and loan association, insurance
company, or registered investment adviser, or if the employee
benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment
decisions made solely by persons that are accredited
investors;
o Yes o No
(ii) Any private business
development company as defined in section 302(a)(22) of the Investment Advisers Act of
1940;
o Yes o No
(iii) Any organization
described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar
business trust, or partnership, not formed for the specific purpose
of acquiring the securities offered, with
total assets in excess of $5,000,000;
o Yes o No
(iv) Any director, executive
officer, or general partner of the issuer of the securities being offered or sold, or any director,
executive officer, or general partner of a general partner of that
issuer;
o Yes o No
(v) Any natural person whose
individual net worth or joint net worth with that person's spouse, at the time of his or her
purchase exceeds $1,000,000;
o Yes o No
For purposes of category (v), the term
"net worth" means the excess of total assets over total liabilities. In computing net worth for
the purposes of category (v) above, the undersigned's principal residence must be valued either at (A)
cost, including the cost of improvements, net of current encumbrances upon the property or (B)
the appraised value of the property as determined upon a written appraisal used by an institutional
lender making a loan to the individual secured by the property,
including the cost of subsequent improvements, net
of current encumbrances upon the property.
25
(vi) Any natural person who
had an individual income in excess of $200,000 in each of the two most recent years or joint
income with that person's spouse in excess of $300,000 in each of
those years and has a reasonable expectation
of reaching the same income level in the current year;
o Yes o No
In determining income, the undersigned
should add to his or her adjusted gross income any amounts attributable to tax exempt income
received, losses claimed as a limited partner in any limited
partnership, deductions claimed for depletion,
contributions to an XXX or Xxxxx retirement plan, alimony payments,
and any amount by which income from
long-term capital gains has been reduced in arriving at adjusted
gross income.
(vii) Any trust, with total
assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities
offered, whose purchase is directed by a sophisticated person as
described in section 230.506(b)(2)(ii);
and
o Yes o No
(viii) Any entity in which
all of the equity owners are accredited investors.
o Yes o No
(b) FOR
NONACCREDITED INVESTORS. I
am not an accredited
investor.
The following information is being
provided here in lieu of furnishing a personal financial
statement.
(i) My net worth excluding
principal residence, furnishings, and automobiles is at least ______________ times the total investment I intend
to make in the Company;
(ii) My annual disposable
income, after excluding all of my personal and family living expenses and other cash requirements for
current obligations, is such that the loss of my entire investment
in the Company would not materially alter
my standard of living;
o Yes o No
(iii) Considering the
foregoing and all other relevant factors in my financial and
personal circumstances, I am able to bear the
economic risk of an investment in the Company.
o Yes o No
26
7. I have previously been
advised that I would have an opportunity to review all the pertinent
facts concerning the Company, and to obtain
any additional information which I might request, to the extent possible or obtainable, without
unreasonable effort and expense, in order to verify the accuracy of
the information provided
me.
8. I have personally
communicated or been offered the opportunity to communicate with
executive officers of the Company to discuss the
business and financial affairs of the Company, its products and activities, and its plans for the
future. I acknowledge that if I would like to further avail myself of
the opportunity to ask additional questions
of the Company, the Company will make arrangements for such an opportunity on
request.
9. I have been advised that
no accountant or attorney engaged by the Company is acting as my representative, accountant, or
attorney.
10. I will hold title to my
interest as follows:
o
|
Community
Property
|
o
|
Separate
Property
|
o
|
Joint Tenants, with Right
of Survivorship
|
o
|
Tenants in
Common
|
o
|
Other (Single Person, Trust, Etc.,
Please Indicate.)
|
||
_________________________________
|
11. I am a bona fide resident
of the state of __________. The address below is my true and correct principal residence.
DATED this 31 day of December , 2007
/s/ Tan Xxx
Xxxx
Name: Tan Xxx
Xxxx
For and on behalf of
Exquisite Foresight,
S/B
27
Exhibit IRL
INVESTMENT REPRESENTATION
LETTER
(TO BE SIGNED BY EACH ACCEPTING
VENDORS)
Re: Purchase of shares of Common
Stock of Renewable Fuel
Corp.
Gentlemen:
In connection with the acquisition by
the undersigned of shares of Common Stock of Renewable Fuel Corp. (the “Securities”), the undersigned
represents that the Securities are being acquired without a view to, or for,
resale in connection with any distribution of such Securities or any interest therein without registration or
other compliance under the Securities Act of 1933, as amended (the "Securities Act"), and that the
undersigned has no direct or indirect participation in any such undertaking
or in the underwriting of such an
undertaking.
The undersigned understands that the
Securities have not been registered, but are being acquired by reason of a specific exemption under the
Securities Act as well as under certain state statutes for transactions by an issuer not involving
any public offering and that any disposition of the subject
Securities may, under certain circumstances, be
inconsistent with this exemption and may make the undersigned an "underwriter" within the meaning of the
Securities Act. It is understood that the definition of an "underwriter" focuses on the concept of
"distribution" and that any subsequent disposition of the subject Securities can only be effected in
transactions which are not considered distributions. Generally, the
term "distribution" is considered synonymous
with "public offering" or any other offer or sale involving general solicitation or general advertising.
Under present law, in determining whether a distribution occurs when securities are sold into the public
market, under certain circumstances one must consider the availability
of public information regarding the issuer,
a holding period for the securities sufficient to assure that the persons desiring to sell the securities
without registration first bear the economic risk of their
investment, and a limitation on the number of
securities which the stockholder is permitted to sell and on the manner
of sale, thereby reducing the potential
impact of the sale on the trading markets. These criteria are set
forth specifically in rule 144 promulgated
under the Securities Act. After one year from the date the Securities
are fully paid for and the subscription is
accepted by the issuer, all as calculated in accordance with rule 144(d),sales
of the Securities in reliance on rule 144 can only be made in limited amounts in
accordance with the terms and conditions of that rule. After
two year from the date the Securities are fully paid for, as
calculated in accordance with rule 144(d), it can
generally be sold without meeting these conditions provided the holder is not (and has not been for the
preceding three months) an affiliate of the issuer.
The undersigned acknowledges that the
Securities must be held and may not be sold, transferred, or otherwise disposed of for value unless
it is subsequently registered under the Securities Act or an
exemption from such registration is available; the
issuer is under no obligation to register the Securities under the Securities Act or under section 12 of
the Securities Exchange Act of 1934, as amended, except as may be expressly agreed to by it in writing; if
rule 144 is available, and no assurance is given that it will be, initially only routine sales of such
Securities in limited amounts can be made in reliance on rule 144 in accordance with the terms and conditions
of that rule; the issuer is under no obligation to the undersigned
to make rule 144 available, except as may
be expressly agreed to by it in writing; in the event rule 144 is
not available, compliance with regulation A
or some other exemption may be required before the undersigned can sell, transfer, or otherwise dispose
of such Securities without registration under the Securities Act;
the issuer's registrar and transfer agent
will maintain a stop transfer order against the registration of transfer
of the Securities; and the certificate
representing the convertible promissory notes and warrants composing
the Securities will bear a legend in
substantially the following form so restricting the sale of such
Securities.
28
THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE "SECURITIES ACT"), AND ARE "RESTRICTED SECURITIES" WITHIN THE
MEANING OF RULE 144 PROMULGATED UNDER THE SECURITIES ACT. THE SECURITIES
HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD OR
TRANSFERRED WITHOUT COMPLYING WITH RULE 144 IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION OR OTHER COMPLIANCE UNDER THE SECURITIES
ACT.
The issuer may
refuse to register transfer of the Securities in the absence of compliance with
rule 144unless the undersigned furnishes the issuer with a "no-action" or
interpretative letter from the U.S. Securities and Exchange Commission or an opinion of
counsel reasonably acceptable to the issuer stating that the
transfer is proper; further, unless such letter
or opinion states that the Securities are free of any restrictions under
the Securities Act, the issuer may refuse to
transfer the Securities to any transferee who does not furnish in writing to the issuer the same
representations and agree to the same conditions with respect to
such Securities as are set forth herein. The
issuer may also refuse to transfer the Securities if any
circumstances are present reasonably indicating that
the transferee's representations are not accurate.
Very
truly yours,
Signed
by:
|
Dated
31 Dec. 2007
|
/s/ Dato’
Xxxxx Xxxxxx Bin Hj. Jaafar
Name: Dato’ Xxxxx
Xxxxxx Bin Hj. Jaafar
NRIC No.
6701420-01-5763
Address: Xx. 0, Xxxxx Xxxxxx Xxxxx,
Xxxxxxxx,
00000 Xxxxxx Xxxxx, Xxxxxxxx Darul Ehsan.
For and on behalf of
Bio-Aspect Sdn. Bhd. (Company No.
733606-X)
29
Exhibit IRL
INVESTMENT REPRESENTATION
LETTER
(TO BE SIGNED BY EACH ACCEPTING
VENDORS)
Renewable Fuel Corp.
Re: Purchase of shares of Common
Stock of Renewable Fuel
Corp.
Gentlemen:
In connection with the acquisition by
the undersigned of shares of Common Stock of Renewable Fuel Corp. (the “Securities”), the undersigned
represents that the Securities are being acquired without a view to, or for,
resale in connection with any distribution of such Securities or any interest therein without registration or
other compliance under the Securities Act of 1933, as amended (the "Securities Act"), and that the
undersigned has no direct or indirect participation in any such undertaking
or in the underwriting of such an
undertaking.
The undersigned understands that the
Securities have not been registered, but are being acquired by reason of a specific exemption under the
Securities Act as well as under certain state statutes for transactions by an issuer not involving
any public offering and that any disposition of the subject
Securities may, under certain circumstances, be
inconsistent with this exemption and may make the undersigned an "underwriter" within the meaning of the
Securities Act. It is understood that the definition of an "underwriter" focuses on the concept of
"distribution" and that any subsequent disposition of the subject Securities can only be effected in
transactions which are not considered distributions. Generally, the
term "distribution" is considered synonymous
with "public offering" or any other offer or sale involving general solicitation or general advertising.
Under present law, in determining whether a distribution occurs when securities are sold into the public
market, under certain circumstances one must consider the availability
of public information regarding the issuer,
a holding period for the securities sufficient to assure that the persons desiring to sell the securities
without registration first bear the economic risk of their
investment, and a limitation on the number of
securities which the stockholder is permitted to sell and on the manner
of sale, thereby reducing the potential
impact of the sale on the trading markets. These criteria are set
forth specifically in rule 144 promulgated
under the Securities Act. After one year from the date the Securities
are fully paid for and the subscription is
accepted by the issuer, all as calculated in accordance with rule 144(d),sales
of the Securities in reliance on rule 144 can only be made in limited amounts in
accordance with the terms and conditions of that rule. After
two year from the date the Securities are fully paid for, as
calculated in accordance with rule 144(d), it can
generally be sold without meeting these conditions provided the holder is not (and has not been for the
preceding three months) an affiliate of the issuer.
The undersigned acknowledges that the
Securities must be held and may not be sold, transferred, or otherwise disposed of for value unless
it is subsequently registered under the Securities Act or an
exemption from such registration is available; the
issuer is under no obligation to register the Securities under the Securities Act or under section 12 of
the Securities Exchange Act of 1934, as amended, except as may be expressly agreed to by it in writing; if
rule 144 is available, and no assurance is given that it will be, initially only routine sales of such
Securities in limited amounts can be made in reliance on rule 144 in accordance with the terms and conditions
of that rule; the issuer is under no obligation to the undersigned
to make rule 144 available, except as may
be expressly agreed to by it in writing; in the event rule 144 is
not available, compliance with regulation A
or some other exemption may be required before the undersigned can sell, transfer, or otherwise dispose
of such Securities without registration under the Securities Act;
the issuer's registrar and transfer agent
will maintain a stop transfer order against the registration of transfer
of the Securities; and the certificate
representing the convertible promissory notes and warrants composing
the Securities will bear a legend in
substantially the following form so restricting the sale of such
Securities.
30
THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE "SECURITIES ACT"), AND ARE "RESTRICTED SECURITIES" WITHIN THE
MEANING OF RULE 144 PROMULGATED UNDER THE SECURITIES ACT. THE SECURITIES
HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD OR
TRANSFERRED WITHOUT COMPLYING WITH RULE 144 IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION OR OTHER COMPLIANCE UNDER THE SECURITIES
ACT.
The issuer may refuse to register
transfer of the Securities in the absence of compliance with rule 144unless the
undersigned furnishes the issuer with a "no-action" or interpretative letter
from the U.S. Securities and Exchange Commission or an opinion of
counsel reasonably acceptable to the issuer stating that the
transfer is proper; further, unless such letter
or opinion states that the Securities are free of any restrictions under
the Securities Act, the issuer may refuse to
transfer the Securities to any transferee who does not furnish in writing to the issuer the same
representations and agree to the same conditions with respect to
such Securities as are set forth herein. The
issuer may also refuse to transfer the Securities if any
circumstances are present reasonably indicating that
the transferee's representations are not accurate.
Very
truly yours,
Signed
by:
|
Dated
31 Dec. 2007
|
/s/ Tan Xxx
Xxxx
Name: Tan Xxx
Xxxx
For and on behalf of
Exquisite Foresight
S/B
31
EXHIBIT A
THE VENDORS
Number of Shares of the
Vendors’ Shares to be Tendered
|
Number of the
Purchaser’s
Common Stock to be
Issued
|
|
Name
|
||
Bio-Aspect
S/B
|
6,300,000
|
51,100,000
|
Exquisite Foresigt
S/B
|
2,700,000
|
21,900,000
|
32
THE COMPANY
SCHEDULES
Schedule
1.01
|
Copy of Corporate Resolution
specifically permitting the Execution and Delivery of the Share Exchange
Agreement
|
Schedule
6.06
|
(a) Information relating
to:
- title to all real and personal property
owned by the Company
- capitalization of the
Company
(b)
Information relating to all Bank
Accounts, Savings Accounts, Deposit Accounts, and other Accounts of the
Company.
(c) List and copies of all Material
Contracts of the Company
(d) List of all outstanding options,
warrants, and other derivative securities of the Company.
(e) List and copies of all professional
contracts, service contracts.
(f) Summary of business operation from
inception through Closing.
(g) Summary of all capital raising
transactions from inception through Closing.
(h)
Copies of any audit reports or opinions
relating to the Company’s ability to continue as a going
concern.
(i) Copies of all
licenses.
(j) Copies of all corporate records,
minutes, books, lists.
(k) List of all outstanding liabilities of
the Company
(l)
Copies of all tax returns, reports,
communications with or from, or documentation filed with applicable governmental
agencies, together with description of any outstanding tax
liabilities.
(m)
Copies of any documentation relating to
any insolvency, claimed insolvency, threatened insolvency or related
proceedings.
33
Renewable Schedules
Exhibit RFC 1 - Copy of Articles of
Incorporation and
Amendments
|
Exhibit RFC 2 - Copy of Renewable Fuel Corp. Bylaws
|
Exhibit RFC 3 - Copy of Corporate Resolution
specifically permitting the Execution and Delivery of the
Share Exchange
Agreement
|
Schedule
6.06
|
(a) Information relating
to:
- title to all real and personal property
owned by the Purchaser
- capitalization of the
Purchaser
(b)
Information relating to all Bank
Accounts, Savings Accounts, Deposit Accounts, and other Accounts of the
Purchaser.
(c) List and copies of all Material
Contracts of the Purchaser
(d)
List of all outstanding options,
warrants, and other derivative securities of the
Purchaser.
(e) List and copies of all professional
contracts, service contracts.
(f) Summary of business operation from
inception through Closing.
(g) Summary of all capital raising
transactions from inception through Closing.
(h)
Copies of any audit reports or opinions
relating to the Purchaser’s ability to continue as a going
concern.
(i) Copies of all
licenses.
(j) Copies of all corporate records,
minutes, books, lists.
(k) List of all outstanding liabilities of
the Purchaser
(l)
Copies of all tax returns, reports,
communications with or from, or documentation filed with applicable governmental
agencies, together with description of any outstanding tax
liabilities.
(m)
Copies of any documentation relating to
any insolvency, claimed insolvency, threatened insolvency or related
proceedings.
34